Trial
NCT04308785
A Study of Atezolizumab With or Without Tiragolumab Consolidation in Limited Stage Small Cell Lung Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Hoffmann-La Roche
Collaborators
—
Condition
Carcinoma, Small Cell Lung
Intervention
Atezolizumab
Why stopped
The sponsor's decision was based on the negative results of SKYSCRAPER-02.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-23